InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (26 ops.)
Insider track record
CFODisclosed buys
0
Disclosed sells
26
T+90 hit rate
75%
T+90 mean return
+1.6%
Across 8 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Dickinson Andrew D, Chief Financial Officer. Insider active across 2 companies, notably Gilead Sciences, INC.. Aggregated, 62 reports have been logged. Split: 0 buy · 26 sells. Total volume traded: €8.1m. History available since 15 August 2021. The latest transaction was filed on 15 April 2026 (Cession). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations62 total
3,000 sharesCommon StockSEC:0001310204-26-000020:0
2,796 sharesCommon StockSEC:0001310204-26-000018:0
1,341 sharesCommon StockSEC:0001310204-26-000018:1
3,000 shares@ US$140.960.0002% mcap7.1% of flowCommon StockSEC:0001310204-26-000014
3,000 shares@ US$140.960.0002% mcap7.1% of flowCommon StockSEC:0001310204-26-000014:0
3,000 shares@ US$144.230.0002% mcap7.5% of flowCommon StockSEC:0001310204-26-000012
3,000 shares@ US$144.230.0002% mcap7.5% of flowCommon StockSEC:0001310204-26-000012:0
3,000 shares@ US$154.437.8% of flowCommon StockSEC:0001310204-26-000006
3,000 shares@ US$154.430.0002% mcap7.8% of flowCommon StockSEC:0001310204-26-000006:0
3,000 shares@ US$124.316.4% of flowCommon StockSEC:0001310204-26-000002
3,000 shares@ US$124.310.0002% mcap6.4% of flowCommon StockSEC:0001310204-26-000002:0
3,000 shares@ US$122.006.2% of flowCommon StockSEC:0001310204-25-000021
3,000 shares@ US$122.000.0002% mcap6.2% of flowCommon StockSEC:0001310204-25-000021:0
2,500 shares@ US$118.085.0% of flowCommon StockSEC:0001310204-25-000014
2,500 shares@ US$118.080.0002% mcap5.0% of flowCommon StockSEC:0001310204-25-000014:0
2,500 shares@ US$113.574.8% of flowCommon StockSEC:0001310204-25-000011
2,500 shares@ US$113.570.0002% mcap4.8% of flowCommon StockSEC:0001310204-25-000011:0
2,500 shares@ US$118.535.1% of flowCommon StockSEC:0001310204-25-000005
2,500 shares@ US$118.530.0002% mcap5.1% of flowCommon StockSEC:0001310204-25-000005:0
2,500 shares@ US$99.821.4% of flowCommon StockSEC:0001127602-25-014718:0
2,500 shares@ US$106.401.5% of flowCommon StockSEC:0001127602-25-012101:0
2,500 shares@ US$110.531.6% of flowCommon StockSEC:0001127602-25-009796:0
4,916 shares@ US$63.911.8% of flowCommon StockSEC:0001127602-25-009283:0
2,500 shares@ US$104.091.6% of flowCommon StockSEC:0001127602-25-005525:0
77,691 shares@ US$63.9130.0% of flowCommon StockSEC:0001127602-25-004784:0
25 of 62 declarations
About Dickinson Andrew D
Andrew D Dickinson is the Chief Financial Officer of GILEAD SCIENCES, INC.
